Monitoring potential neurotoxic effects of hazardous waste disposal by Schaumburg, Herbert H. et al.
Environmental Health Perspectives
Vol. 48, pp. 61-64, 1983
Monitoring Potential Neurotoxic
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This report reviews neurotoxicological principles relevant to situations of hazardous waste
disposal. Some ofthe diagnostic techniques currently used forfield assessment ofnervous system
dysfunction are critically evaluated. These include nerve conduction velocity, evoked potentials,
neuropsychological testing and use of the Optacon.
Hazardous waste disposal sites generally expose
large populations to toxins. Although outbreaks of
neurotoxicity have yet to be definitely linked to
waste disposal sites, it is possible that such out-
breaks may occur in the future. Several situations
may be envisioned (1). The simplest situation would
be human exposure to substances, such as mercury
orkepone, that are knownto produce characteristic
neurological abnormalities. This situation is best
met by surveying at-risk individuals for body fluid
levels and neurological dysfunction (tremor, nys-
tagmus). Amore difficultproblemisthe appearance
ofneurological abnormalities in individuals exposed
to chemicals not considered neurotoxic. Here one
must carefully define the illness and then link it to
one ormore agents byexperimentalanimal studies.
The present report reviews neurotoxicological
factors relevant to this problem and discusses the
techniques commonly used to assess individuals
exposed to known neurotoxins.
Neurotoxicological Factors
Substances that produce structural change in the
nervous system usually result in diffuse disease of
susceptible subsystems. Especially vulnerable sub-
systems are: peripheral nerves, long pathways of
the spinal cord, the cerebrum and the cerebellum.
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Focal orasymmetrical disorders ofthese structures
(e.g., aphasia, mononeuropathy) are generally not
oftoxicorigin. Toxicneurologicdiseasemayprofitably
beconsidered toreflectattackonvariouscomponents
ofnervous tissue: axons, neurons, myelin, glial and
bloodvessels. Thefirsttwocomponentsareespecially
important, andwhenattacked, theresultingdiseases
arecalledtoxicaxonopathyandtoxicneuronopathy.
The specific clinical, pathological and physiological
characteristicsoftheseconditionshavebeenrecently
reviewed (2).
The biochemical basis of most neurotoxic condi-
tions is unknown, and the chemical formula of an
untested substance is frequently not predictive of
neurotoxicity. For example, it is now clear that the
gamma-diketone moiety is an essential feature
underlying aliphatic hexacarbon neurotoxicity. If
the two keto groups are differently spaced in the
molecule, the compound is frequently harmless
(e.g., 2,5-heptanedione is neurotoxic, 2,6-heptane-
dione is not).
Acute and chronic exposure to the same sub-
stance may result in a dramatically variable clinical
picture (e.g., acutehigh-levelexposuretoacrylamide
causes atoxic encephalopathy with convulsions and
hallucinations, while low-level, chronic exposure
causesdistalaxonopathy; alsoacutehigh-levelexpo-
sure to n-hexane results in narcosis, but low-level,
chronic exposure produces a distal axonopathy).
Subclinical or asymptomatic dysfunction of the
nervous system can occur and may go undetected
for a prolonged time.SCHAUMBURG, SPENCER AND AREZZO
Noninvasive
Neurodiagnostic Techniques
There are formidable obstacles in screening for
toxic disease of the nervous system, especially
when compared to more accessible, readily moni-
tored systems (e.g., blood, skin). In addition, the
most accurate noninvasive diagnostic techniques
(e.g., computerized imaging), aimed at structural
or vascular abnormalities, are of limited use in
neurotoxicology. The clinical neurotoxicologist usu-
ally must rely heavily on the limited tools of
physical examination, clinical electrophysiology and
neuropsychology. Nerve conduction velocity and
evoked potential studies are amongthe most widely
employed electrophysiological maneuvers to detect
peripheral and central nervous system dysfunction.
Behavioral or cognitive disturbances are usually
evaluated by standard psychological tests modified
forrapid screeningoflargepopulations. Thissection
briefly reviews the use and misapplication of these
techniques.
Determinations of nerve conduction velocity are
now routinely used for the assessment ofperipheral
neuropathy. Measurement ofmotorconductionveloc-
ity is simple, noninvasive, can be performed with
portable equipment and is widely employed in field
assessmentofpolyneuropathy. Maximalmotor nerve
conduction velocity is determined by percutaneous
stimulation of a mixed peripheral nerve at two or
more proximal sites while recording the onset
latency of an evoked muscle action potential by
surface electrodes from a distal muscle. Sensory
conduction studies may also use cutaneous stimula-
tion, surface electrodes and standard oscilloscope
recording; however, response variability is fre-
quent when the test is performed under these
conditions. Such studies record only the largest
diameter myelinated fibers, and these may or may
not be affected. Optimal assessment of peripheral
nerve function requires the use of multiple stimuli
and averaging techniques, which define the wave
shape of the compound nerve action potential. The
total distribution ofconduction velocities can be cal-
culated from the average wave form. Under these
latter conditions, the assessment of sensory nerve
function becomes a powerful diagnostic tool. Other
valuable electrodiagnostic techniques such as the
collision procedure (for detecting small-fiber dys-
function), stimulus trains, F-wave studies and as-
sessment of the H-reflex (for assessing proximal
conduction velocity) are also available but rarely
used in field studies.
Axonal neuropathies, in their early stages,
generally produce only slight slowing of motor and
sensory conduction which may be limited to a
specific subset ofaxons (e.g., large-diameter myeli-
nated fibers). In addition, many commonneurotoxic
substances produce distal axonal degeneration, so
that nerve-conduction studies at proximal sites are
oflimited value. The range ofvalues for motor and
sensory conduction velocities and sensory ampli-
tude is large (as performed under field conditions),
and minor variations in nerve conduction velocity
are subject to over interpretation unless scrupu-
lously controlled. In sum, considerable expertise,
mature judgment and the appropriate equipment
are required to select and perform the correct
procedures and interpret data from nerve conduc-
tion studies accurately. Whenever possible, such
studies should be performed in a modern, well-
equippedelectrodiagnosticlaboratorythatroutinely
utilizes averaging techniques and has extensive
experience with normal individuals. Many reported
field studies appear poorly controlled and are
seriously flawed by inadequate sampling that does
not permit statistical analysis. The Danish report
of lead-exposed workers stands as an example of
a meticulous peripheral electrodiagnostic study,
whose data can withstand considerable statistical
scrutiny (3).
Recent advances in computer-averaged evoked
potentials enable the noninvasive recording of syn-
chronous activity at a distance from its source
within the nervous system. Such "far-field" data
principally reflect afferent activity within fiber
tracts and can be combined with previously defined
components ofcortical origin to provide a complete
index of the integrity of each of the major sensory
systems. The possible effects of n-hexane (4),
xylene and alcohol (5) on the human visual system,
and those oflead (6) on the somatosensory system,
have been investigated in man by using the evoked
potential technique. Both amplitude and latency
measures have been employed in human studies,
but the latency measures appear more reliable.
Spatio-temporalanalysisofsurface-recordedevoked
potentials has permitted monitoring portions of
tracts most vulnerable to specific toxicants. Our
recent work in the monkey, utilizing lower-extrem-
ity stimulation, has demonstrated that the distal
extreme of axons within the long pathways of the
gracile fasciculus show early degeneration follow-
ing exposure to acrylamide (6 ).
It is hoped that similartechniques to test humans
exposed to neurotoxins will become feasible. The
use ofevoked potentials as a neurological screening
procedure appears limited both by the variability of
this measure when applied to populations at large
and the current lack of standard recording proce-
dures among laboratories. The latency and ampli-
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tude of far-field components are significantly in-
fluenced by the age, skin temperature and size of
the subject, while cortical components are addi-
tionally influenced by the precise location of the
recording electrode and the attention level of the
individual.
Neuropsychological deficitsthathavebeenreported
in association with exposure to toxicants include:
disturbances in intelligence, memory, and problem
solving as well as alterations in attention, psycho-
motor functioning and mood (8,9). Detection of
these effects in a large, previously unstudied popu-
lation is difficult. Clinical evaluation of case histo-
ries can help in determining the extent of these
problems, but this often is highly subjective and
descriptions of the symptoms are usually vague.
Subtle alterations inpsychological functioningclearly
can go unnoticed by both physician and subject.
Psychological evaluation, using a battery of stan-
dard tests, is the only available procedure capable
ofproviding objective and quantifiable results regard-
ing behavioral deficits. Selection ofthe appropriate
test is critical because of the considerable time
requirements for this for;m ofevaluation and should
be based on a careful review of preliminary obser-
vations. A common misuse of neuropsychological
testing is overinterpretation of selected portions of
the data. The quantitative results are often quite
variable both within and across subject measure-
ments. Additional problems are absence of stan-
dardization and nonspecificity ofmany ofthe avail-
abletests. Sincepsychologicaldatacanbesignificantly
influenced by the predisposition ofboth subject and
experimenter, these tests should be scored in a
double-blind fashion. Whenever possible, psycho-
logical data should be correlated with biochemical
or physiological findings. The recent study ofmem-
ory performance in polybrominated biphenyl (PBB)-
exposed individuals exemplifies a carefully con-
trolled and well-executed investigation of neuro-
psychological status and should serve as amodel for
future work in this area (10). In this study, 46
subjects were examined by using six memory tests;
the body burden of chemical was monitored by
chemical analysis offat biopsies, and the psycholog-
ical data were subjected to the appropriate multi-
variate analysis. In sum, it is apparent that tech-
niques currently used in neurotoxicity screening
programs are crude, subject to variation and fre-
quently misinterpreted or wrongly applied.
Screening can be much more effective if the
diagnostic technique is targeted at a specific func-
tion vulnerable to the neurotoxin in question. For
example, we have recently designed a rapid, reli-
able and quantifiable test offingertip sensation that
may prove applicable in screening programs for
some neurotoxins (11). The rationale for this test
was derived from our experimental studies of
acrylamide-intoxicated cats, which indicated that
the most sensitive structure was the axon of the
toe-pad Pacinian corpuscle (12,13). The appropriate
clinical manifestation ofsuch early pathophysiologi-
cal changes would be loss of vibration sense. Since
the Pacinian corpuscle was so exquisitely vulnera-
ble, and elevation of vibratory threshold is a
feature common to several toxic neuropathies, we
elected to monitor vibration sensation. We tested
the modified Optacon, a portable electronic device
which, in its unmodified state, converts visual
imagesintotactilefonns. Theinstrumentisdesigned
for use by blind persons, who rest their index
finger-pad on a grid composed of 144 small metal
rods which vibrate. Baseline testingwas performed
on 124 subjects; a normal group of 52 male and 48
females, and a clinical group of 11 males and 13
females undergoing treatment for diabetes (a com-
mon cause of peripheral neuropathy). In normal
subjects there was striking consistency in the mean
sensory threshold determined at various times and
alinear increase in threshold with age. The diabetic
population was more variable and contained several
subjects with markedly elevated thresholds. The
study suggested the potential usefulness of the
modified Optacon as a simple, reliable technique for
detecting sensory loss and abnormal metabolic or
toxicconditions. Recently, nursesinchemicalplants
have been trained to field test individuals and have
obtained reliable (14) thresholds. Four data points
are collected per annum for each subject. It is
hoped that the Optacon will also prove useful in
certain specialty medical clinics (diabetes, renal,
oncology), where individuals susceptible to distal
axonopathy require frequent assessment in a longi-
tudinal fashion.
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